Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  elotuzumab
Find trials that include:  Any drugs shown
Results 1-5 of 5 for your search:
Start Over
Bortezomib, Dexamethasone, and Lenalidomide with or without Elotuzumab in Treating Patients with Newly Diagnosed High-Risk Multiple Myeloma
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: S1211, NCI-2012-01998, CDR0000738512, PS1211_A12PAMDREVW01, SWOG-S1211, NCT01668719
Elotuzumab and Lenalidomide with or without Dexamethasone in Treating Patients with High-Risk Smoldering Multiple Myeloma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14-338, NCI-2014-02644, CA 204-119, CA 204-119 (BMS), RV-CL-MM-PI-004473 (Celgene), RV-CL- MM-PI-004473, NCT02279394
Bortezomib, Lenalidomide, Dexamethasone and Elotuzumab in Treating Patients with Newly Diagnosed Multiple Myeloma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14-453, NCI-2015-00898, NCT02375555
Elotuzumab and Lenalidomide after Stem Cell Transplant in Treating Patients with Newly Diagnosed Multiple Myeloma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2014-0729, NCI-2015-00762, NCT02420860
Start Over